Tissue-resident macrophages can develop from circulating adult monocytes or from primitive yolk sac-derived macrophages. The precise ontogeny of alveolar macrophages (AMFs) is unknown. By performing BrdU labeling and parabiosis experiments in adult mice, we found that circulating monocytes contributed minimally to the steady-state AMF pool. Mature AMFs were undetectable before birth and only fully colonized the alveolar space by 3 d after birth. Before birth, F4/80 hi CD11b lo primitive macrophages and Ly6C hi CD11b hi fetal monocytes sequentially colonized the developing lung around E12.5 and E16.5, respectively. The first signs of AMF differentiation appeared around the saccular stage of lung development (E18.5). Adoptive transfer identified fetal monocytes, and not primitive macrophages, as the main precursors of AMFs. Fetal monocytes transferred to the lung of neonatal mice acquired an AMF phenotype via defined developmental stages over the course of one week, and persisted for at least three months. Early AMF commitment from fetal monocytes was absent in GM-CSF-deficient mice, whereas short-term perinatal intrapulmonary GM-CSF therapy rescued AMF development for weeks, although the resulting AMFs displayed an immature phenotype. This demonstrates that tissue-resident macrophages can also develop from fetal monocytes that adopt a stable phenotype shortly after birth in response to instructive cytokines, and then self-maintain throughout life.
Alveolar macrophages (AMF) are the proto typical MFs of the lung that have important functions in lung development, surfactant ho meostasis, pathogen clearance, and immune homeostasis (Lambrecht, 2006) . Among tissue resident MFs, AMFs have a peculiar phenotype in that they are highly autofluorescent, express low levels of the phagocytic receptor CD11b, yet high levels of the integrin CD11c, and high levels of the lectin SiglecF, allowing them to be easily recognized among other myeloid cells of the lung (Gautier et al., 2012b; Misharin et al., 2013) . For a long time, AMFs were considered the prototypical cells belonging to the unified mononuclear phagocyte system (MPS), a family of tissueresident MFs proposed to derive from circulating BMderived monocytes that seed the various tissues in the steady state and continu ously differentiate locally into tissueresident MFs (van Furth and Cohn, 1968; Geissmann et al., 2010) . The MPS concept with the circulating monocyte as the central precursor to all tissue MFs was based on in vivo adult monocyte transfer experiments (Geissmann et al., 2003) , in vivo thymidine(3)H labeling experiments (van Furth and Cohn, 1968) , and the study of irradiation chimeras (Virolainen, 1968) . Deple tion of AMFs using intratracheal administration tissueresident MFs, we readdressed the origin of AMFs and found that these cells are not replenished continuously from adult monocytes, but instead derive from fetal monocytes that seed the lung before birth and develop into longlived CD11c hi , SiglecF hi AMFs shortly after birth in response to an instructive signal provided by granulocyteMF colonystimulating factor (GMCSF). In GMCSF-deficient mice, a few days of peri natal cytokine therapy were able to restore AMF development for weeks. Differentiation of AMFs from fetal monocytes starts around the time alveoli develop (E18.5), and is completed over the course of 1 wk. These findings reconcile previous contro versies on AMF ontology and provide new clues to the devel opmental origin of this unique MF population resident in the lung compartment from fetal monocytes.
RESULTS

Identification of lung mononuclear cells
We first addressed if AMFs derived from a circulating precur sor population. To precisely define the different mononuclear cells of the lung, we performed 10color flow cytometry on bronchoalveolar lavage (BAL) fluid and total lung cell suspen sions after blood was rinsed from the pulmonary circulation. First, neutrophils (Ly6G hi CD11b hi CD64 lo Ly6C hi cells), eosin ophils (SiglecF hi CD11b hi CD64 lo Ly6C int cells), T cells (CD3 hi CD11b lo CD64 lo cells), and B cells (CD19 hi CD11b lo CD64 lo cells) were outgated (unpublished data). Second, not to miss any mononuclear cells, we first gated lung cells on a broad mono nuclear gate consisting of F4/80 + and CD11b + cells. AMFs have a distinct phenotype among tissueresident MFs and can be unequivocally identified within the F4/80 + CD11b + gate as SiglecF hi CD11c hi cells in the BAL fluid (Fig. 1 A; Gautier et al., 2012b) . The same population could also be found in total cell suspensions of lung tissue ( Fig. 1 B) , when BAL fluid was not collected before homogenization. In lung tis sue, the F4/80 + CD11b + gate contained a second population of CD11b hi F4/80 int cells that were further subdivided into CD11c lo SiglecF lo cells and CD11c int SiglecF lo cells. Using this gating strategy, SiglecF hi CD11c hi cells were large (FSC hi ), and granular (SSC hi ) highly autofluorescent cells (Fig. 1 C) , typi cal of alveolar MFs (Vermaelen and Pauwels, 2004) . We next measured the expression of various markers on these three identified populations of lung cells (Fig. 1 C) . The universal MF marker CD64 was expressed highly on SiglecF hi CD11c hi AMFs, but not on the other two populations. The marker Ly6C is highly expressed on circulating monocytes, but less on monocytes that patrol the blood vessels (Geissmann et al., 2003) . The CD11b hi F4/80 int CD11c lo SiglecF lo population expressed of diphtheria toxin (DT) to CD11cDT receptor (DTR) mice followed by transfer of monocytes demonstrated that adult BMderived monocytes can indeed differentiate into AMFs in vivo (Landsman and Jung, 2007) . However, genetic fate map ping experiments using hematopoietic (Myb) or monocyte based (Cx3cr1) fate mapping gene promoters found these cells to be only partially (Schulz et al., 2012) or not at all (Yona et al., 2013) of adult hematopoietic or monocytic origin, which was hard to reconcile with the MPS concept. Part of the confu sion on the precise origin of AMFs also stems from the fact that these cells are long lived and relatively radioresistant de pending of the radiation dose, complicating the interpretation of radiation chimeric experiments. Therefore, whereas some proposed a monocytic origin for AMF (Godleski and Brain, 1972; van oud Alblas and van Furth, 1979; Kennedy and Abkowitz, 1997; Kennedy and Abkowitz, 1998) others pro posed that AMFs would be mainly longlived, selfrenewing cells (Tarling et al., 1987; Murphy et al., 2008) .
The MPS paradigm with the circulating monocyte as the central replenisher of all tissue MFs has also been challenged recently by the observation that MFs appear in embryonic tissues before the development of monocytes, making it hard to envisage a precursorproduct relationship for monocytes and MFs (Takahashi et al., 1989; Ginhoux et al., 2010; Hoeffel et al., 2012; Schulz et al., 2012) . Supporting the idea of primi tive MF progenitors seeding the tissues, some tissueresident MFs like microglia (Ajami et al., 2007 (Ajami et al., , 2011 and Kupffer cells (Bouwens et al., 1986a,b; Yamamoto et al., 1996) were found not to derive from circulating hematopoietic precursors but to be longlived, selfrenewing cells. Using genetic fate map ping, microglia was found to be derived from fetal yolk sac MFs that seed the brain before birth and then maintain locally without any input from adult hematopoietic precursors or circulating monocytes (Ginhoux et al., 2010) . When first pro posed, the primitive origin of microglia was thought to rep resent an exception to the MPS concept, as microglia populate a cellular niche that is normally not accessible to hematopoi etic precursors because of the blood-brain barrier that closes shortly before birth. However, subsequent studies found that most tissueresident MFs, including Kupffer cells, splenic MFs, peritoneal MFs, and kidney MFs, are not of adult hemato poietic origin in the steady state (Schulz et al., 2012; Yona et al., 2013) , leading to the generalization that these cells may also develop directly from yolk sac-derived fetal MFs (Gomez Perdiguero et al., 2013) .
Given the controversies surrounding the development of AMFs and these recent developments on the origin of other distinguished as CD45.1 + CD45.2 + cells, were gated out, and the remaining BM-derived cells of the indicated populations were analyzed for their ratio of CD45.1 + WT and CD45.2 + CCR2 / cells. (E) Summary data from five independent chimeric mice. (F) Parabiotic mice were generated by suturing together CD45.1 + WT and CD45.2 + CCR2 / mice. The percentage of cells of CD45.1 + WT donor origin was determined in B cells, neutrophils, and monocytes in the blood and AMFs in the lungs of the CD45.2 + CCR2 / parabionts. (G) Adult C57BL/6 mice received BrdU continuously for 28 d. Mice were sacrificed at regular intervals, and incorporation of BrdU in lung AMFs and monocytes was evaluated. (H) Adult C57BL/6 mice were sacrificed and Ki-67 expression (left) was determined in AMFs. The isotype staining is shown (right). Data represent at least three (A-E) or two (F-H) independent experiments involving at least six (E) and four (F and G) independent mice. monocyte egress from the BM in the CD45.2 + Ccr2 / mice, donor CD45.1 + WT monocyte constituted 80% of the mono cytes in these mice. However, in our experiments AMFs achieved a much lower chimerism in parabionts with <5% of AMFs originating from the parabiotic partner. This indicates that circulating adult hematopoietic precursors only minimally participate to the AMF pool. These data are congruent with a recent report from the Merad group (Hashimoto et al., 2013) .
We next sought to find evidence for the lack of monocyte contribution to the AMF pool in unmanipulated mice. We reasoned that if monocytes were precursors to AMFs, then studying BrdU incorporation kinetics should allow us to study progenitor-product relationships (Kamath et al., 2002) . We exposed C57BL/6 mice continuously to BrdU in the drink ing water for 4 wk after an initial i.p. injection of BrdU. As shown in Fig. 1 G, whereas almost all monocytes were rapidly BrdU labeled within 2 d, AMFs slowly accumulated 30% of BrdU incorporation after 4 wk of continuous BrdU exposure. The slow accumulation of BrdU could come from BrdU + circulating hematopoietic progenitors or from local prolifera tion of AMFs. We therefore evaluated the expression of the cell cycle protein Ki67, which labels dividing and recently divided daughter cells. As shown in Fig. 1 H, a small popula tion (<5%) of Ki67 + dividing cells could be found among AMFs, suggesting a slow local proliferation of AMFs.
To further evaluate whether circulating monocytes con tribute to the AMF pool of unmanipulated mice, we trans ferred 2 × 10 6 CD45.1 + Ly6C hi CD11b hi monocytes into adult Ccr2 / CD45.2 + mice, but we could not recover any transferred monocyte developing into SiglecF hi CD11c hi AMFs 7 d after the transfer, although we readily recovered trans ferred monocytes as mature intestinal MFs 7 d after transfer (not depicted; Tamoutounour et al., 2012; Bain et al., 2013) . Alveolar MFs appear in the alveolar space during the first week of life Microglia and Langerhans cells (LCs) derive from embryonic precursors that seed the brain and the skin before birth and maintain themselves locally throughout life (Chorro et al., 2009; Ginhoux et al., 2010; Hoeffel et al., 2012) . As AMFs also did not derive from circulating monocytes and showed signs of lowgrade proliferation, we next addressed the ontogeny of AMF before and after birth. Little is known about the ontog eny of the lung immune system in relation to lung development, which proceeds via a pseudoglandular stage (E9.5-E16.5), a canalicular stage (E16.5-17.5), and a saccular stage (E18.5 to postnatal day [PND] 5). During the latter stage, canaliculi de velop numerous sacs that are the precursors to the alveoli. As shown in Fig. 2 A, we first measured the kinetics of CD45 + leukocyte accumulation in the lung. The percentage of CD45 + cells started expanding around E18, coinciding with the start of the saccular stage (Fig. 2 C) . We next addressed the ontog eny of mononuclear cells (Fig. 2 B) Adult circulating monocytes contribute to the AMF pool in irradiated mice, but not in homeostasis Previous work supporting the fact that AMFs belong to the MPS system have studied AMF pool replenishment after wholebody irradiation, illustrating that the AMF pool can derive from an adult hematopoietic progenitor. However, it has not been formally shown that circulating monocytes con stitute the main precursor of the AMF pool after irradiation, or only participate minimally to the AMF pool. To test this, congenic mice coexpressing CD45.1 and CD45.2 were le thally irradiated and reconstituted with a 1:1 mixture of BM cells isolated from CD45.1 + C57BL/6 WT mice and from CD45.2 + Ccr2 / mice. These B6 (CD45.1) WT + B6 (CD45.2) Ccr2 / → B6 (CD45.1-CD45.2) competitive chimeras were analyzed 8 wk after BM transfer. As CCR2 is critical for egress of monocytes from the BM (Serbina and Pamer, 2006) , competitive chimerism allowed us to address the relative contribution of circulating monocytes to AMF replenishment after whole body irradiation. As expected, Ly6C hi blood monocytes were primarily composed of CD45.1 + CCR2 + donor cells, whereas neutrophils and B cells were comprised of almost equal percentages of CD45.1 + and CD45.2 + donor cells ( Fig. 1 D, group summarized in Fig. 1 E) . 8 wk after reconstitution, AMFs still contained between 5 and 10% of hostderived, radioresistant CD45.1 + CD45.2 + cells, illustrating the relative radioresistance of these cells (Fig. 1 E) . The donorderived AMFs showed CD45 chimerism identical to those of Ly6C hi blood monocytes, demonstrating that upon severe depletion, AMFs derive from circulating monocytes.
We next questioned whether circulating monocytes par ticipate to the AMF pool in the adult life when AMFs are not experimentally depleted by irradiation. We therefore per formed parabiosis experiments between CD45.1 + WT mice and CD45.2 + Ccr2 / mice. After 8 wk of parabiosis, we ana lyzed the contribution of CD45.1 + WT cells within the CD45.2 + Ccr2 / mice. There was an almost even distribution of long lived recirculating cells, and donor CD45.1 + WT B lympho cytes represented 40% of circulating blood B lymphocytes of the parabiont CD45.2 + Ccr2 / partner ( Fig. 1 F) . However, shortlived circulating cells like neutrophils exchanged 20% of the cells among the parabiont partner. Such uneven distribu tion between parabionts likely results from the fact that neutro phils do not spend enough time in the circulation to equilibrate between the parabionts (Liu et al., 2007) . Due to a defect in SiglecF lo CD11c lo cells still contained some Ly6C lo F4/80 hi fetal MFs, but Ly6C hi F4/80 int fetal monocytes were the pre dominant population. Within the SiglecF lo CD11c lo cells, some monocytes had already lost Ly6C, a common feature of mono cytes differentiating into mature MFs or DCs (Tamoutounour et al., 2012; Plantinga et al., 2013) . Between PND1 and PND3, SiglecF hi CD11c hi cells appeared very suddenly, and these were Ly6C lo F4/80 hi cells, like adult AMFs. The SiglecF lo CD11c int cells contained more MHCII DCs (not depicted), but still con tained many mononuclear cells that were losing Ly6C. At PND3 (Fig. 3 , A-C, third column), the SiglecF lo CD11c lo frac tion hardly contained any F4/80 hi fetal MFs anymore. At PND14 (Fig. 3 , A-C, fourth column), the ensemble of lung mononuclear cell types resembled the adult state, and the CD11c int population had lower mean fluorescence expression of SiglecF. In Fig. 3 E, the relative distribution of all these cell populations is plotted against time. The appearance of mature AMFs at PND3 was preceded by a surge in SiglecF lo CD11c int CD64 int cells that looked like immature AMFs on SEM. We will therefore call this population preAMFs.
Fetal monocytes give rise to self-maintaining AMFs through a preAMF intermediate step
To verify whether fetal monocytes or fetal MFs are the direct precursors to AMFs, we designed a competitive transfer ex periment (Fig. 4) . CD45.1 fetal MFs and CD45.2 monocytes were isolated from E17 lungs and transferred together in a 1:1 ratio i.n.) into CD45.1 + CD45.2 + mice on their DOB, i.e., when the AMF niche is still empty. 7 d after transfer, the fate of the donor cells was evaluated. Whereas at day 7, most of the AMFs were of host CD45.1 + CD45.2 + phenotype in these nonirradiated mice (Fig. 4 A) , the fate of donor cells could clearly be defined. As shown in Fig. 4 (A and B) , transferred AMFs were significantly more derived from fetal monocytederived MFs than from fetal MFs. Similar results were found when the congenic donor pair was switched over (i.e. when fetal monocytes were CD45.1 and fetal MFs were CD45.2) or when the recipient mice were analyzed at 6 weeks after transfer (unpublished data) instead of 7 days after transfer (Fig. 4, A and B) . A similar setup also allowed us to follow the differentiation of developing AMFs from adoptively transferred fetal monocytes. Therefore, we i.n. transferred fetal CD45.1 + monocytes into CD45.2 + mice on DOB and checked the phenotypic changes of the cells in the following days and weeks. Strikingly, transferred CD45.1 cells could be found up to 11 wk after transfer (Fig. 4 C) . Fetal monocytes gradually increased expression of CD11c, SiglecF, F4/80, and CD64 lev els, while downregulating first Ly6C and then CD11b, going through a Ly6C int CD11b hi F4/80 int Ly6C int CD64 int interme diate stage, essentially validating these cells as preAMFs. The kinetic of the differentiation of the transferred monocytes fits a developmental scheme that would go from fetal monocytes over preAMFs to mature AMFs within 6 to 7 d, which was also seen in Fig. 3 E. We could still trace back AMF originating from transferred monocytes 3 mo after transfer. Moreover, within one transfer experiment, the percentage of donorderived were completely negative for SiglecF and CD11c. They were most reminiscent of the phenotype of primitive MFs that arise at E9 and E12 from the yolk sac, and are also CD11b int F4/80 hi (unpublished data). Progressively, the mononuclear gate be came replete with a second F4/80 int CD11b hi population, and there was a gradual increase in the cells expressing intermedi ate levels of CD11c. However, before birth, the mononuclear gate was completely devoid of SiglecF hi CD11c hi AMFs. Around the date of birth (DOB), the mononuclear gate was in transi tion, and it was no longer possible to clearly discern F4/80 hi from F4/80 int cells. There was a marked increase in CD11c int cells. Mature SiglecF hi CD11c hi AMFs only appeared between PND1 and PND3, when a predominant population of F4/80 hi cells was again apparent in the mononuclear gate. Interestingly, this time point coincided with the first appearance of large mononuclear cells in the alveolar space (Fig. 2 D) . Mature SiglecFexpressing AMFs were first found in the lung septa at PND1, and accumulated in the alveolar lumen at PND3 (Fig. 2 E) . When we studied lungs before birth, the develop ing airspaces were completely devoid of mononuclear cells ( Fig. 2 D and E) . Therefore, bona fide SiglecF hi CD11c hi AMFs only appear in the alveolar space during the first days of life.
Fetal MFs, fetal monocytes, preAMFs, and mature AMFs appear in consecutive waves during lung development The kinetic analysis of lung mononuclear cells and AMF on tology demonstrated that the phenotype of lung mononuclear cells was highly dynamic, and composed of cells resembling fetal monocytes, fetal MFs, and immature AMFs, with signifi cant overlap in expression of marker sets. We therefore studied the phenotype of mononuclear cells in greater detail, again using the basic mononuclear gate and three populations CD11c hi SiglecF hi , CD11c int SiglecF lo , and CD11c lo SiglecF lo as the starting gate, just like in adult mice (Fig. 3 A) . As illus trated in Fig. 3 B for the E17 time point, most mononuclear cells were SiglecF lo CD11c lo cells that could be readily subdivided into CD11b int F4/80 hi and CD11b hi F4/80 int cells. These cells also differentially expressed the monocytic marker Ly6C (Fig. 3 B) . Ly6C lo F4/80 hi cells highly expressed CD64 (Fig. 3 C) , a core MF marker (Gautier et al., 2012b; Tamoutounour et al., 2012) , showed a typical MF morphology on SEM (Fig. 3 D) , and adhered to plastic in vitro. On the contrary, Ly6C hi F4/80 int did not express CD64 and had the typical monocytic FSC lo SSC lo profile (not depicted) and displayed a nonadherent monocytic morphology on scanning electron microscopy (SEM; Fig. 3 D) , thus constituting fetal monocytes. Given their kinetic appear ance and resemblance to fetal liver monocytes (not depicted), these were likely derived from the liver, the major hematopoietic organ at this time period of development. From E18 onwards, but culminating around DOB (Fig. 3, A-C, second column) , a predominant population of SiglecF lo CD11c int cells appeared. These cells were mainly CD11b hi F4/80 int and were Ly6C int and expressed intermediate levels of CD64. On SEM, these cells were larger and more granular like AMFs, but did not adhere well to plastic (Fig. 3 D, preAMF) . Very few MHCII + DCs were found in this gate (data not shown). At DOB, the has been linked to nonfunctional GMCSF signaling in patients (Suzuki et al., 2008) and could be reproduced in genetically modified mice lacking GMCSF (Csf2 / ) or GMCSFR (Csf2r / ) expression (Huffman et al., 1996; Reed et al., 1999; Reed et al., 2000; Zsengellér et al., 1998) . Although the PAP syndrome was originally proposed to derive from the fact that AMFs were not functional in these mice (REFs; Golde, 1976, cells among mature AMFs only dropped very slowly during adult life (Fig. 4 D) , suggesting that transferred monocytes gave rise to a stable selfmaintaining population.
GM-CSF drives the development of preAMFs around birth
Primary pulmonary alveolar proteinosis (PAP) is a disease as sociated with the accumulation of surfactant in the lungs that (isolated at E17), fetal MFs (isolated at E17), preAMFs (isolated at the DOB), and mature AMFs (isolated from adult mice) were sorted, put in culture in vitro overnight in complete medium, and subjected to electromagnetic microscopy to assess their capacity to adhere to cell culture plastic and general morphology. (E) Percentage of fetal MFs, fetal monocytes, preAMFs, and mature AMFs among CD45 + cells in the lungs at the indicated time points. Data in A-E represent at least two independent experiments involving at least three independent mice per time point.
we decided to investigate the development of AMFs in Csf 2 / mice. On their DOB, Csf2 / mice completely lacked preAMFs (Fig. 5 C) . However, they contained fetal MFs and monocytes in ratios similar to WT mice (see Fig. 3 for comparison) . Note that the small CD11c int population that was found in Csf2 / mice on DOB was Ly6C int , but had a SiglecF lo CD64 lo FSC lo SSC lo profile. Therefore, the wave of preAMFs that is found in WT mice around birth is absent in Csf2 / mice. Importantly, de velopment of preAMFs or mature AMFs remained absent in Csf2 / mice throughout life (Fig. 5 E) . Liver and splenic CD11b int F4/80 hi resident MFs, however, could be readily identified in Csf2 / mice (Fig. 5, F and G) . In contrast, we 1979; Harris, 1979; GonzalezRothi and Harris, 1986; Nugent and Pesanti, 1983; LeVine et al., 1999; Yoshida et al., 2001; Paine et al., 2001; Thomassen et al., 2007) , Shibata et al. (2001) later proposed that a MF developmental defect rather than a func tional defect may lie at the basis of the disease. However, it is not known how absence of GMCSF signaling impacts on AMF ontogeny before and shortly after birth. We found that lung epithelial cells show an increased expression of GMCSF mRNA that is paralleled by high GMCSF protein levels in lung tissues around DOB, yet quickly wanes thereafter (Fig. 5,  A and B) . Because fetal MFs, fetal monocytes, preAMFs, and mature AMFs all express the GMCSFR (CD116, Fig. 5 D) , others have described AMFs with functional defects in adult Csf2 / mice. To characterize these cells, we first performed a Percoll gradient to remove debris and dead cells form the BAL fluid and then used a more general MF gating strategy using F4/80 and CD64 (Fig. 5 H) . In doing so, we could indeed had great difficulty identifying MFs in the BAL of Csf2 / mice. Proteinosis had already developed by 4 wk of age and yielded autofluorescent debris in the BAL fluid. The presence of many dead cells (unpublished data) also rendered the analy sis of the cellular composition of the BAL difficult. However, rGMCSF treatment (Fig. 6 C) , but were unable to significantly inhibit the development of PAP, as measured by the amount of protein content in the BAL fluid, suggesting that they were not only phenotypically but also functionally immature (Fig. 6 D) . To verify whether these rGMCSF-rescued immature AMFs were irreversibly blocked in the immature AMF stage or whether these cells merely lacked the proper cellular environ ment to differentiate into mature AMFs we designed a trans fer experiment in which immature CD11c hi SiglecF int CD11b hi AMFs from cytokinetreated CD45.2 Csf2 / mice were transferred into a neonatal WT CD45.1 GMCSF replete hosts (Fig. 7) . The phenotype of transferred cells was evaluated 2, 9, and 42 d after transfer. As shown in Fig. 7 , immature AMFs gradually further increased expression of CD11c, SiglecF, F4/80, and CD64 expression and, as a final step in their mat uration process, downregulated CD11b expression until they were undistinguishable from mature AMFs.
DISCUSSION
It is a longheld belief that all MFs develop from circulat ing monocytes and constitute a unified MPS, but MFs have identify some rare F4/80 + CD64 + cells in the BAL of Csf2 / mice. These cells did not express a bona fide AMF profile, but were found to be SiglecF lo CD11b hi CD11c int Ly6C hitoint . Moreover we could only identify such cells after 4 wk of age, i.e., once the first signs of PAP developed.
Perinatal GM-CSF cytokine therapy restores the generation of self-maintaining preAMFs in Csf2 / mice Given the surge of GMCSF expression in the perinatal period, and given the fact that AMFs can selfmaintain throughout life once generated, we reasoned that perinatal recombinant GMCSF treatment of Csf2 / mice during the first days of life might be sufficient to rescue arrested AMF development. Treat ment of neonatal Csf2 / mice through local i.n. administra tion of rGMCSF on 1, 3, or 5 consecutive days, lead to the dose dependent development of cells with a CD11c int SiglecF inthi that resembled AMFs, but had lower expression of SiglecF, and had not yet downregulated CD11b and upregulated F4/80 as bona fide mature AMFs (Fig. 6 , B and C). Such rescued Csf2 / AMFs could selfmaintain for several weeks after the the microglia model and originate from yolk sac MFs (Gomez Perdiguero et al., 2013) .
Here, using radiation chimeric mice, parabiosis, and adop tive cellular transfer models, we investigated the ontogeny of AMFs. Confirming the CX 3 CR1monocyte fatemapping studies in adult mice (Yona et al., 2013) , we demonstrate that circulating BMderived monocytes contribute only minimally to the pool of AMFs, except when mice are lethally irradiated, emptying the AMF niche. We therefore conclude that there must be a selfmaintaining, proliferating pool of MFs in the lung. During the completion of this manuscript, another group reported similar conclusions, showing that this pool of self maintaining lung MFs can even fill up the AMF niche after AMF depletion caused by influenza infection or DTmediated depletion (Hashimoto et al., 2013) .
The fact that adult circulating monocytes only mini mally feed the steadystate AMF pool suggested an embryonic recently been shown to develop from primitive precursors before birth (Geissmann et al., 2010) . Both pathways of devel opment might be mutually exclusive or coexist. Indeed, micro glia originate directly from yolk sac MFs that colonize the brain before birth, and then selfmaintain throughout life without any input from BMderived precursors (Ajami et al., 2007; Ginhoux et al., 2010) . However, we and others have shown that intestinal MFs derive directly from BMderived monocytes that continuously seed the lamina propria and differentiate locally into MFs (Bogunovic et al., 2009; Varol et al., 2009; Tamoutounour et al., 2012) . The specific cellular origin of other tissueresident MFs remains unknown, but elegant fatemapping experiments have demonstrated that BMderived precursors contribute minimally to the pool of most tissueresident MFs across tissues (Schulz et al., 2012; Yona et al., 2013) . Based on analogy with microglia, it was proposed therefore that most tissueresident MFs may follow and partly from Mybindependent primitive precursors, al though it was hard to conclude from the gating strategy whether AMFs were included in the analysis, and whether other myeloid populations expressing F4/80 such as eosino phils were excluded from analysis (Schulz et al., 2012) . This group also showed that in Mybdeficient embryos, which lack fetal monocyte development, an F4/80 hi MF population was present in the fetal lung. However, as these Mybdeficient em bryos never reach term and die from severe anemia at E16.5, it is not possible to assess whether these F4/80 hi MFs would indeed become AMFs, as AMFs only appear after birth. Moreover, the F4/80 hi cells identified in the lungs of the Mybdeficient embryos around E16 are most likely the primi tive yolk sac MFs that we also see peaking around this time point in WT mice (Fig. 3) .
It is remarkable that fetal MFs and monocytes were de scribed by Ginhoux et al. (2010) to colonize the developing skin at the same time points as we recovered them in the de veloping lung, with fetal monocytes giving rise to a special ized subset of dendritic cells called LCs (Hoeffel et al., 2012) . In fact, AMFs and LCs share several unique features: (a) they populate a cellular niche where they constitute the only antigen presenting cell in the steady state (the alveoli and the epider mis, respectively); (b) the alveolar and the epidermal niche are not easily accessible to hematopoietic precursors as these are barriers to the outside world, probably requiring the LCs and AMFs to selfmaintain in the steady state; (c) AMFs (this study) and LCs (Chorro et al., 2009; Hoeffel et al., 2012) col onize their niches in a single wave during the first week after birth; and (d) fatemapping studies demonstrate that AMFs (Ginhoux et al., 2010) and LCs (Hoeffel et al., 2012) do not derive from yolk sac MFs, but instead derive primarily from fetal monocytes (this study ; Hoeffel et al., 2012) .
The environmental cues that drive AMF and LC differen tiation, however, seem to differ significantly. LCs require IL34, but not MCSF or GMCSF Greter et al., 2012b; Wang et al., 2012) , whereas AMFs require GM CSF and MCSF, but not IL34 for their development (this study; Wang et al., 2012; Hashimoto et al., 2013) . Around the perinatal period, we noticed high expression of GMCSF mRNA in epithelial cells and protein in BAL fluid, but this waned rapidly after birth. Analysis of Csf2 / mice demon strated that lungs were completely devoid of AMFs, identify ing GMCSF as the driving cytokine for AMF development in the perinatal period. Previous work on Csf2 / or Csf2r / mice with pulmonary alveolar proteinosis (PAP) reached con flicting results stating that AMF function was impaired (Golde, 1976 (Golde, , 1979 Harris, 1979; Nugent and Pesanti, 1983; Gonzalez Rothi and Harris, 1986; LeVine et al., 1999; Yoshida et al., 2001; Paine et al., 2001; Thomassen et al., 2007) , or that AMF development was abnormal (Shibata et al., 2001) . Here, we show that AMF development is blocked before the preAMF stage, and the few MFs that are found in Csf2 / mice are most likely inflammatory MFs that accumulate in response to lung damage inflicted by surfactant accumulation. Given the boost of GMCSF expression in the perinatal period, and precursor, and decided to take a closer look at the nature of this embryonic precursor. In our developmental analysis, we did not solely rely on expression of the pan MF markers CD64, F4/80, and CD11b, but also took advantage of the unique and discriminating surface characteristics of mature AMFs that express high levels of SiglecF and CD11c. A clearly de fined phenotype of the mature tissueresident MF, allowed us to also look for intermediate steps in AMF development, a task almost impossible for other tissueresident MFs for which such late maturation markers are often lacking. The early de veloping lung (E12, before fetal liver hematopoiesis has started) contained mainly F4/80 hi CD11b int Ly6C  CD64 hi cells that had a phenotype and ultrastructure like primitive MFs and did not express AMF markers. From E14 onwards, we also observed a steady increase in fetal monocytes in the developing lung. As definitive hematopoiesis starts only from E16.5, these were most likely derived from fetal liver hemato poiesis (Costa et al., 2012) . Cells with a preAMF phenotype started accumulating in the fetal lung around the saccular stage of lung development (E18.5), when branching canaliculi become narrower and give rise to saccules, which are the pre cursors to alveoli (Morrisey and Hogan, 2010) . Bona fide ma ture SiglecF hi CD11c hi AMFs only appeared during the first week after birth, and not before birth, as shown for microglia (Ginhoux et al., 2010) .
As both fetal monocytes and fetal MFs were found in the developing lung, the question remained as to which of these two were the progenitor to AMFs. Based on kinetic analysis, phenotypic changes after adoptive transfer, and competitive reconstitution experiments, we concluded that fetal mono cytes were the main progenitors to AMFs. First, adoptive transfer of E17 fetal monocytes was much more efficient in generating longterm engraftment of AMFs compared with transfer of E17 fetal MFs. Second, when E17 fetal monocytes were transferred and followed over time, they differentiated gradually into AMFs, first downregulating Ly6C and ac quiring CD11c expression, followed by SiglecF acquisition. The final step of AMF maturation was accompanied by fur ther upregulation of SiglecF, downregulation of CD11b and upregulation of F4/80. This entire process took 7 d, which would also fit with the kinetics of appearance of the first lung fetal monocytes (E14) over an intermediate stage preAMF stage around DOB and with the appearance of mature AMFs at PND13. Third, when adoptively transferred, fetal mono cytes gave rise to a longterm population of AMFs that were almost not diluted over time. Others have shown, using fate mapping experiments, that AMFs do not derive from E7 Runx1 MERCreMER RosaLSLYFP-tagged yolk sac MFs (Ginhoux et al., 2010) or from adult CX3CR1 ERCre Rosa LSLYFP-tagged mononuclear cells (Yona et al., 2013) , but have offered no explanations as to where exactly AMFs do derive from. Our study provides direct evidence that fetal monocytes are the predominant progenitor to AMFs. One group has proposed, using an inducible MxCredriven Myb deficiency abolishing adult hematopoietic cells, a mixed ori gin of lung MFs, partly deriving from adult hematopoietic MFs follow the microglia model (yolk sac MF origin), the intestinal MF model (BMmonocyte origin), or the AMF/LC model (fetalmonocyte origin).
MATERIALS AND METHODS
Mice. C57BL/6 CD45.2 + , congenic C57BL/6 CD45.1 + (The Jackson Laboratory), Csf2 / and Ccr2 / mice were bred at the animal facility of the University of Ghent. For timed pregnancies, female C57B1/6 or GMCSF mice were superovulated with 2 i.u. pregnant mare serum gonadotropin (Folligon; Intervet) to stimulate follicle growth and 2 i.u. human chorionic gonadotropin (Chorulon; Intervet) to induce ovulation. Mice were housed under specific pathogen-free conditions in individually ventilated cages in a controlled day-night cycle and given food and water ad libitum. All ex periments were approved by the animal ethical committee of the University of Ghent.
Generation of BM chimeras and parabiotic mice. C57BL/6 (CD45.1 + CD45.2 + ) mice were lethally irradiated with two doses of 5.5 Gy, and re ceived i.v. 2 × 10 6 BM cells consisting of a 50:50 mix of BM cells obtained from femurs and tibias of WT C57BL/6 CD45.1 + and of C57BL/6 Ccr2 / CD45.2 + mice. 7 wk after reconstitution, proper blood chimerism was veri fied, and mice were analyzed 8 wk after BM transfer.
Parabiotic mice were generated by suturing weightmatched CD45.1 + and CD45.2 + mice of 9 wk of age. Parabiotic mice were then kept under Bactrim for 2 mo before analysis. As previously described (Liu et al., 2007) , circulating B cells and T cells equilibrated to almost 50% chimerism at that time, indicating efficient exchange between the joined mice.
BrdU labeling in vivo and cell cycle analysis. Mice were injected i.p. with 1.5 mg BrdU (SigmaAldrich) to ensure its immediate availability, and their drinking water was supplemented for up to 28 d with 0.8 mg/ml of BrdU and 2% glucose and changed daily. Lung cells were stained first for surface markers and then permeabilized for BrdU staining (BrdU labeling Flow kit; BD). Ki67 staining (BD) was performed using the staining proto col corresponding to the Foxp3 labeling Flow kit (eBioscience).
Flow cytometry and cell sorting. Flow cytometric studies were per formed using a LSRII (BD) with subsequent data analysis using FlowJo soft ware (Tree Star). Cell sorting was performed on a FACSAria II cytometer. After cell sorting, purity was checked (always >95%). For flow cytometry, lungs were cut into small pieces, incubated in RPMI containing Liberase TM (Roche) and DNase (Roche), and then syringed through a 19gauge needle to obtain a homogenous cell suspension. Red blood cells were lysed for 4 min at room temperature in 1 ml osmotic lysis buffer. For flow cytometry of BAL derived from GMCSF mice diagnosed with proteinosis, BAL cells were first enriched using a Percoll gradient (SigmaAldrich).
Fluorochrome or biotinconjugated mAbs specific for mouse CD11c (clone N418), CD3 (clone 1452C11), CD19 (clone 1D3), Ly6G (clone 1A8), CD11b (clone M1/70), CD64 (clone X545/7.1), Ly6C (clone AL21), SiglecF (clone E502440), SAV, Ki67 (clone B56), Sca1 (clone d7), CD45.1 (clone A20), and CD45.2 (clone 104); the corresponding isotypes; and the secondary reagent PETexas red-conjugated streptavidin were all purchased from BD or eBioscience. AntiMHCII (clone M5/114) and anti Epcam (clone G8.8) were purchased from BioLegend. AntiF4/80 (clone A31) was purchased from Serotec. Neutrophils (Ly6G hi CD11b hi CD64 lo Ly6C hi cells), Eosinophils (SiglecF hi CD11b hi CD64 lo Ly6C int cells), T cells (CD3 hi CD11b lo CD64 lo cells), and B cells (CD19 hi CD11b lo CD64 lo cells) were systematically outgated before analysis. Fixable live/dead marker Aqua was purchased from Invitrogen. Dead cells were outgated using the live/marker before analysis.
Transfer of sorted cells. Fetal monocytes and fetal MFs were sorted from the lungs of timemated E17 C57BL/6 CD45.2 + and CD45.1 + embryos.
given the fact that AMFs can selfmaintain throughout life once generated, we reasoned that perinatal recombinant GMCSF treatment of Csf2 / mice during the first days of life might be sufficient to rescue arrested AMF development. Perinatal GMCSF for 5d treatment, indeed, rescued long term CD11c hi SiglecF int AMF development, AMFs appeared in the alveolar lumen, but these AMFs were in an immature state, failing to downregulate CD11b and to prevent PAP. It is possible that 5 d of GMCSF treatment of Csf2 / mice was insufficient to cause full AMF differentiation, or that continuous lowlevel GMCSF production in a replete host induces a second signal permissive to terminal AMF differen tiation. In support, adoptive transfer of immature AMFs from GMCSF-treated Csf2 / mice to WT mice allowed the ter minal differentiation of immature AMFs, a process that took a few days. We can only speculate as to what exactly this sec ond signal might be. Previous work identified PPAR as a crucial transcription factor for AMF development necessary to prevent PAP (Baker et al., 2010; Gautier et al., 2012a) . GMCSF induces PPAR gene expression (Bonfield et al., 2003) . However, we administered the PPAR agonist rosigli tazone in the perinatal period, and this failed to terminally differentiate AMFs in GMtreated Csf2 / mice (unpub lished observations). Studies in humanized mice confirm the essential role of GMCSF in human AMF development. Mouse GMCSF does not bind to human GMCSFR, and therefore these humanized mice do not possess human AMFs. Mice in which the mouse Csf2 locus was replaced by the human coding sequence lacked murine AMFs (Willinger et al., 2011) , and without engraftment of human HSCs they developed PAP. After human HSC engraftment, MFs of human origin were found in the BAL, but these MFs were incapable of fully protecting against PAP. This suggests that, in humans as well as in mice, GMCSF alone may not be suffi cient to generate fully functional and terminally differenti ated AMFs. Strikingly, a recent paper also identified GMCSF as the cytokine necessary for the proliferation and self maintenance of AMFs after local depletion from the lungs (Hashimoto et al., 2013) .
In conclusion, we have elucidated the pathway of AMF development by showing that fetal monocytes develop into preAMFs around the time that airspaces (fluid filled sac culi) start to occur during lung development. At the DOB, most preAMFs are still in the alveolar septa, but shortly thereafter they end up in the alveolar space as immature AMFs, and then rapidly downregulate CD11b and be come functionally mature cells that selfmaintain and do not require input from circulating hematopoietic precur sors. Importantly, the appearance of such preAMFs seems to be restricted to a single wave around birth and accompa nied by a boost of GMCSF around this period, which is necessary for proper AMF instruction. In the broader con text of MF development, we provide evidence for a third model for the origin of tissueresident MF, whereby AMFs originate from fetal monocytes during the perinatal period. It remains to be investigated whether other tissueresident
